Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 427 of 427 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/01/10
End: 07/25/16
Due: 07/25/17
Phase: N/A
Priority: Normal
Start: 04/01/02
End: 02/15/07
Due: 02/15/08
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML) | NCT01074047 | Celgene | user2@example.com | None | 2010-06-01 | 2016-07-25 | 2017-07-25 | - | - | 2025-07-14 |
| CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma | NCT00044018 | Celgene | user2@example.com | None | 2002-04-01 | 2007-02-15 | 2008-02-15 | - | - | 2025-07-14 |